(2021). Benefits and harms of replacement therapy with Alpha 1 Antitrypsin in patients with documented enzyme deficiency and Chronic Obstructive Pulmonary Disease: A systematic review and network meta-analysis.
Chicago Style (17th ed.) CitationBenefits and Harms of Replacement Therapy with Alpha 1 Antitrypsin in Patients with Documented Enzyme Deficiency and Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-analysis. 2021.
MLA (8th ed.) CitationBenefits and Harms of Replacement Therapy with Alpha 1 Antitrypsin in Patients with Documented Enzyme Deficiency and Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-analysis. 2021.
Warning: These citations may not always be 100% accurate.